BBH

BBH
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
About VanEck Biotech ETF
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
GILD | Gilead Sciences, Inc. | 14.42% | 388.12K | $53.96M |
AMGN | Amgen Inc. | 14.28% | 152.80K | $53.45M |
VRTX | Vertex Pharmaceuticals Incorporated | 7.84% | 66.71K | $29.36M |
REGN | Regeneron Pharmaceuticals, Inc. | 7.17% | 35.95K | $26.83M |
ARGX | argenx SE | 5.78% | 26.72K | $21.62M |
IQV | IQVIA Holdings Inc. | 4.28% | 93.18K | $16.03M |
INSM | Insmed Incorporated | 4.19% | 103.76K | $15.68M |
ALNY | Alnylam Pharmaceuticals, Inc. | 4.08% | 45.89K | $15.28M |
NTRA | Natera, Inc. | 3.97% | 73.56K | $14.85M |
RVMD | Revolution Medicines, Inc. | 3.96% | 108.81K | $14.83M |
UTHR | United Therapeutics Corporation | 3.66% | 23.73K | $13.71M |
BIIB | Biogen Inc. | 3.54% | 75.06K | $13.24M |
ONC | BeOne Medicines Ltd. | 3.30% | 40.42K | $12.35M |
MRNA | Moderna, Inc. | 3.06% | 225.76K | $11.44M |
ILMN | Illumina, Inc. | 2.54% | 74.75K | $9.49M |
BNTX | BioNTech SE | 2.32% | 89.62K | $8.67M |
INCY | Incyte Corporation | 2.25% | 88.32K | $8.44M |
NBIX | Neurocrine Biosciences, Inc. | 1.83% | 54.35K | $6.87M |
TECH | Bio-Techne Corporation | 1.47% | 95.32K | $5.48M |
BMRN | BioMarin Pharmaceutical Inc. | 1.34% | 91.13K | $5.00M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
GILD
Gilead Sciences, Inc.
AMGN
Amgen Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
ARGX
argenx SE
IQV
IQVIA Holdings Inc.
INSM
Insmed Incorporated
ALNY
Alnylam Pharmaceuticals, Inc.
NTRA
Natera, Inc.
RVMD
Revolution Medicines, Inc.
UTHR
United Therapeutics Corporation
BIIB
Biogen Inc.
ONC
BeOne Medicines Ltd.
MRNA
Moderna, Inc.
ILMN
Illumina, Inc.
BNTX
BioNTech SE
INCY
Incyte Corporation
NBIX
Neurocrine Biosciences, Inc.
TECH
Bio-Techne Corporation
BMRN
BioMarin Pharmaceutical Inc.
